Advanced Cardiovascular, Inflammation & Diabetes Risk

$68.99

$65.99 member save $3.00

Join for Member Savings

Become a member to unlock discounted pricing and exclusive perks.

This Extended Lipid Panel quantifies the components of a typical lipid panel (TC, HDL-C and TG) along with ApoB by nuclear magnetic resonance (NMR) spectroscopy. Results can be used to assist in CVD risk assessment. GlycA is a composite biomarker that integrates protein levels and glycosylation states of several acute-phase proteins, offering a stable measure of systemic inflammation. The Diabetes Risk Index (DRI) is a nuclear magnetic resonance spectroscopy (NMR)-derived multimarker score that predicts a patient's risk of developing type 2 diabetes mellitus (T2D) independent of glycemic status. DRI derives its performance from the weighted addition of the Lipoprotein Insulin Resistance Index (LP-IR) scores with simultaneously-measured levels of branched-chain amino acids (BCAA).

Quick facts

Sample type

Serum or plasma

Turnaround

2–4 business days

Fasting

No Fasting Required

Doctor’s order included

Licensed physician review and requisition included with every test.

Advanced Cardiovascular, Inflammation & Diabetes Risk

  • Heart Health
  • Diabetes & Blood Sugar
  • General Health & Wellness
  • Cpt Codes
    • 80061
    • 81599
    • 82172
    • 0024U

    what is Advanced Cardiovascular, Inflammation & Diabetes Risk and why is it important?

    This Extended Lipid Panel quantifies the components of a typical lipid panel (TC, HDL-C and TG) along with ApoB by nuclear magnetic resonance (NMR) spectroscopy. Results can be used to assist in CVD risk assessment. GlycA is a composite biomarker that integrates protein levels and glycosylation states of several acute-phase proteins, offering a stable measure of systemic inflammation. The Diabetes Risk Index (DRI) is a nuclear magnetic resonance spectroscopy (NMR)-derived multimarker score that predicts a patient's risk of developing type 2 diabetes mellitus (T2D) independent of glycemic status. DRI derives its performance from the weighted addition of the Lipoprotein Insulin Resistance Index (LP-IR) scores with simultaneously-measured levels of branched-chain amino acids (BCAA).
    • If you have a family history of early heart disease, stroke, or diabetes.
    • If you are managing conditions like high blood pressure, high cholesterol, or insulin resistance.
    • When you want to understand if chronic inflammation is contributing to your health concerns.
    • If you are overweight, have an unhealthy diet, or lead a sedentary lifestyle, and want to assess your metabolic risk.
    • As part of a proactive wellness strategy to gain deeper insights into your long-term health risks.
    • Individuals seeking a comprehensive assessment of their cardiovascular risk beyond traditional cholesterol numbers.
    • Those interested in understanding their body's inflammation status as it relates to long-term health.
    • People with a family history of heart disease, stroke, or diabetes.
    • Anyone wanting to evaluate their personal risk for developing type 2 diabetes, even if their current blood sugar levels are normal or in the prediabetes range.
    • Individuals looking to monitor the effectiveness of lifestyle changes or treatments aimed at improving metabolic and cardiovascular health.

    This advanced panel is a crucial tool for healthcare providers to assess and manage various interconnected health conditions. It is commonly used for:

    • Understanding and stratifying the risk of Cardiovascular Diseases (CVD), including atherosclerosis, heart attack, and stroke, by evaluating comprehensive lipid profiles and Apolipoprotein B.
    • Identifying and monitoring chronic systemic inflammation, which is often a silent contributor to various diseases and overall health decline.
    • Assessing an individual's predisposition and current risk for developing Type 2 Diabetes Mellitus, offering insights beyond standard glucose metrics.
    • Evaluating metabolic health status and identifying signs of insulin resistance or metabolic syndrome.
    • Guiding lifestyle interventions and treatment strategies for patients with dyslipidemia or those at risk for metabolic and cardiovascular complications.

    Caution

    It's important to remember that this test provides valuable information, but it should always be interpreted in the context of your overall health history, lifestyle, and other diagnostic findings by a qualified healthcare provider. Factors like recent illness, injury, or inflammation can influence results, especially for GlycA. This test is a tool to help you and your doctor make informed decisions about your health, not a standalone diagnosis.

    How It Works?

    1
    Add Your Test to Cart and Check out

    once Test Order is received, Our physicians will review your request and email you the easy-to-follow requisition form.


    2
    Locate and Visit Your Nearest Laboratory

    Find the closest partner location—most are within 2–3 miles—and drop by for a quick, no‑appointment blood draw.


    3
    Get your Results Online

    Once your sample is processed, we’ll send your report straight to your inbox within 1–3 business days. Just click the link to view your results anytime.


    4
    Book a Optional Consult

    Have Questions about results? Book a phone or video visit with one of our doctors. They’ll walk you through your report, explain any findings, and recommend next steps